Prospective Assessment of Impact of Personalized Dosing of Low-dose Human Chorionic Gonadotropin (hCG) on in Vitro Fertilization (IVF) Outcomes

Stopped early · Not applicable

Conditions studied: Infertility, Female

In brief

The purpose of the study is to determine the effect of tailoring dosage of low-dose hCG secondary to serum hCG levels during IVF ovarian stimulation on sustained implantation rates of preimplantation genetically tested euploid embryos.

Key facts

Study ID
NCT04852029
Run by
Reproductive Medicine Associates of New Jersey
People needed
12
Starts
2021-08-16
Expected to finish
2021-12-31
Last updated by the study team
2022-01-28

Who can join

Age: 18 and older, up to 46. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.